CClinicalTrials.gg
CompletedNCT06386367Updated Apr 29, 2024

Health Education by Buddhist Monks to Promote Malaria Knowledge and Preventive Practices in Rural Myanmar

An interventional study of Monastery-based health education by Buddhist monks in Buddhist Monks, Health Education and Malaria, sponsored by Myanmar Health Network Organization. Completed at 1 site in Myanmar. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-29.

Sponsored by Myanmar Health Network Organization · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
501
Allocation
Non-randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Malaria is still a leading public health concern in Myanmar. However, people living in rural areas usually showed poor prevention practice despite residing in malaria hotspots. The majority in Myanmar are Buddhists who frequently visit the monastery and receive the speech delivered by the monks. In a malaria high burden township of the Sagaing Region from northern Myanmar, current study will first explore the difference in malaria preventive practices among people residing in different malaria-endemic villages through a mixed-methods approach. Next, this research will address the knowledge gaps by a monastery-based health education delivered by trained Buddhist monks using standardized health messages instruction for six consecutive months between August 2022 to January 2023. To test whether the intervention could balance those gaps among different groups, quantitative data of baseline, 3-month, and 6-month will be compared using descriptive statistics, chi-square test, T-test or repeated ANOVA, and the Difference-In-Differences (DID) analysis, as applicable.

02

Conditions studied

  • Buddhist Monks
  • Health Education
  • Malaria
  • Monastery-based
  • Myanmar
  • Preventive Practice

Browse trials for

03

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

For educational intervention; - voluntary participation

For questionnaire surveys;

  • male or female household leaders or immediate family members
  • aged >18 years who had resided in the study villages for more than one year

Exclusion criteria

Exclusion Criteria:

For questionnaire surveys;

  • Individuals who were unable to communicate effectively or were under the influence of narcotics, including alcohol
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
501 participants (actual)

Study arms

  • Experimental
    Monastery-based health education intervention

    The education sessions were conducted in Burmese by trained monks. They followed the normal teachings of the Buddhist doctrine and typically lasted 30-40 minutes. Our research utilized Burmese as the medium for delivering health messages, and all accompanying materials were meticulously prepared in Burmese. The study team observed at least one to two education sessions in each study village.

    Behavioral: Monastery-based health education by Buddhist monks

  • No intervention
    Control

    Participants in the control group just received routine malaria control services such as diagnostic, treatment and bed net distribution.

Interventions

  • BehavioralMonastery-based health education by Buddhist monks

    During the three-month intervention from July to September 2022, a total of 18 health education sessions were conducted across the three intervention villages, with an average of 50 attendees per session, totaling 921 attendees across all sessions.

05

What researchers measure

Primary outcomes

  1. Malaria knowledge and preventive practices

    To assess pre-existing malaria knowledge and preventive practices among both intervention and control groups, pre-intervention surveys were conducted. Subsequently, three- and six-month post-intervention surveys were conducted to evaluate changes following the intervention. A validated questionnaire translated from English to Burmese was used. The questionnaire comprised three sections: demographic information of the respondents, knowledge of malaria and preventive practices. Each section had multiple small questions, and each correct answer was scored. The resultant scores were aggregated, wherein every participant had the potential to accrue a maximum of ten points pertaining to the attribution of malaria causation, symptoms of malaria, and adoption of personal preventative measures against malaria. The participants were eligible to secure eight points in the domain of malaria diagnosis and treatment, alongside twelve scores for the use of LLINs.

    Time frame: Pre intervention (July 2022), 3-month post-intervention (Dec 2022) and 6-month post-intervention (Mar 2023)

06

Study locations

1 site
  • Myanmar Health Network Organization
    Yangon, 11091, Myanmar
07

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT06386367
Lead sponsor
Myanmar Health Network Organization
Collaborators
Chulalongkorn University, Ministry of Health and Sports, Myanmar
Responsible party
Pyae Linn Aung (Principal Investigator, Myanmar Health Network Organization) — Principal investigator
First posted
Apr 26, 2024
Start date
Jul 1, 2022
Primary completion
Mar 31, 2023
Completion
Mar 30, 2024
Last update
Apr 29, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion